Clinical Trial

Spatial Memory Training and Cognitive Function

Recruiting
View on ClinicalTrials.gov →
Summary
Mild cognitive impairment (MCI) is often considered a transitional stage between normal aging and dementia, particularly Alzheimer's disease (AD). Patients with MCI have subjective memory complaints corroborated by standard neuropsychological tests but remain functionally autonomous. One of the first brain regions to show AD pathology is the hippocampus (HPC). Reduction in HPC volume is a strong predictor of AD dementia. Therefore, improvement or restoration of HPC structure and function is thus an attractive target for improvement in memory and AD prevention strategies. In the current study, the investigators propose to examine the effects of a 3-month long spatial memory program on spatial memory and the hippocampus in patients diagnosed with MCI. Neuropsychological tests are also administered before and after the training to assess the effects of the intervention on cognition. In our previous research, the investigators have shown that spatial memory intervention program (SMIP) improves cognition and hippocampal based spatial memory compared to controls.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-31; most recent amendment 2025-07-18.
Status change: Not Yet Recruiting → Recruiting 2025-06-27
Trial Details
NCT Number NCT07002996
Lead Sponsor Douglas Mental Health University Institute
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Mild Cognitive Impairment
Enrollment 80 participants
Start Date 2025-06-15
Primary Completion 2030-09-30 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-23